VEGFA and neoplasm: BEV inhibits tumor growth by preventing VEGF from binding to its receptor, thereby inhibiting tumor vascular endothelial cell proliferation and angiogenesis, reducing vascular permeability, and promoting tumor blood vessel degradation6.